MeSH Browser

MeSH Heading: Angiotensin II
Tree Number(s): D06.472.699.094.078; D12.644.400.070.078; D12.644.456.073.041; D12.644.548.058.078; D12.776.631.650.070.078; D23.469.050.050.050
Unique ID: D000804
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/D000804
Scope Note: An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS.
Entry Term(s): 5-L-Isoleucine Angiotensin II; ANG-(1-8)Octapeptide; Angiotensin II, Ile(5)-; Angiotensin II, Isoleucine(5)-; Angiotensin II, Val(5)-; Angiotensin II, Valine(5)-; Angiotensin-(1-8) Octapeptide; Isoleucine(5)-Angiotensin; Isoleucyl(5)-Angiotensin II; Valyl(5)-Angiotensin II
Pharm Action: Vasoconstrictor Agents
Related Numbers: 4474-91-3
CAS Type 1 Name: Angiotensin II
See Also: Renin-Angiotensin System
Public MeSH Note: 1974; see ANGIOTENSIN 1971-1973, see ANGIOTENSIN 1967-1970; ANGIOTENSIN was heading 1964-1978, was HYPERTENSIN 1963 (HYPERTENSIN see ANGIOTENSIN 1964-1965, see ANGIOTENSIN AMIDE 1966-1973); ANGIOTENSIN II, ILE(5)- was indexed under ANGIOTENSIN II 1981-1999, and ISOLEUCINE 1975-1981
History Note: 1974(1963); for ANGIOTENSIN II, ILE(5)- use ANGIOTENSIN II (NM) 1974-1999
Date Established: 1974/01/01
Date of Entry: 1999/01/01
Revision Date: 2016/07/05

Allowable Qualifiers: administration & dosage (AD)

adverse effects (AE)

agonists (AG)

analogs & derivatives (AA)

analysis (AN)

biosynthesis (BI)

blood (BL)

cerebrospinal fluid (CF)

chemical synthesis (CS)

chemistry (CH)

classification (CL)

deficiency (DF)

drug effects (DE)

economics (EC)

genetics (GE)

history (HI)

immunology (IM)

isolation & purification (IP)

metabolism (ME)

pharmacokinetics (PK)

pharmacology (PD)

physiology (PH)

poisoning (PO)

radiation effects (RE)

standards (ST)

supply & distribution (SD)

therapeutic use (TU)

toxicity (TO)

urine (UR)

Hormones, Hormone Substitutes, and Hormone Antagonists [D06]
- Hormones [D06.472]
  - Peptide Hormones [D06.472.699]
    - Angiotensins [D06.472.699.094]

Amino Acids, Peptides, and Proteins [D12]
- Peptides [D12.644]
  - Neuropeptides [D12.644.400]
    - Angiotensins [D12.644.400.070]

Amino Acids, Peptides, and Proteins [D12]
- Peptides [D12.644]
  - Oligopeptides [D12.644.456]
    - Angiotensins [D12.644.456.073]

Amino Acids, Peptides, and Proteins [D12]
- Peptides [D12.644]
  - Peptide Hormones [D12.644.548]
    - Angiotensins [D12.644.548.058]

Amino Acids, Peptides, and Proteins [D12]
- Proteins [D12.776]
  - Nerve Tissue Proteins [D12.776.631]
    - Neuropeptides [D12.776.631.650]
      - Angiotensins [D12.776.631.650.070]
        
        Angiotensin I [D12.776.631.650.070.075]
        
        Angiotensin II [D12.776.631.650.070.078]
        
        Angiotensin III [D12.776.631.650.070.080]

Biological Factors [D23]
- Inflammation Mediators [D23.469]
  - Autacoids [D23.469.050]
    - Angiotensins [D23.469.050.050]

Angiotensin II Preferred

Concept UI: M0001202
Related Numbers: 4474-91-3
Scope Note: An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS.
Terms: Angiotensin II Preferred Term
Term UI T002385
Date01/01/1999
LexicalTag NON
ThesaurusID INN (19XX); Angiotensin-(1-8) Octapeptide
Term UI T002384
Date09/12/1988
LexicalTag NON
ThesaurusID UNK (19XX); ANG-(1-8)Octapeptide
Term UI T002386
Date08/08/1988
LexicalTag NON
ThesaurusID UNK (19XX)

Angiotensin II, Val(5)- Narrower

Angiotensin II, Ile(5)- Narrower

Concept UI: M0055996
Terms: Angiotensin II, Ile(5)- Preferred Term
Term UI T086000
Date11/08/1999
LexicalTag NON
ThesaurusID NLM (2000); 5-L-Isoleucine Angiotensin II
Term UI T365873
Date11/08/1999
LexicalTag NON
ThesaurusID; Isoleucyl(5)-Angiotensin II
Term UI T002388
Date03/31/1982
LexicalTag NON
ThesaurusID UNK (19XX); Angiotensin II, Isoleucine(5)-
Term UI T085999
Date11/08/1999
LexicalTag NON
ThesaurusID NLM (2000); Isoleucine(5)-Angiotensin
Term UI T365872
Date11/08/1999
LexicalTag NON
ThesaurusID NLM (2000)

Angiotensin II MeSH Descriptor Data 2025